Impact of intraoperative blood loss on long-term survival after lung cancer resection

Annals of Thoracic and Cardiovascular Surgery

Volumn 21, Issue 1, 2015, Pages 18-23

  Nakamura, Haruhiko ^a   Saji, Hisashi ^a   Kurimoto, Noriaki ^a   Shinmyo, Takuo ^a   Tagaya, Rie ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Intraoperative blood loss; Lobectomy; Lung cancer; Prognosis; Surgery

Indexed keywords

ADENOCARCINOMA; ADVERSE EFFECTS; AGE; AGED; CANCER STAGING; COMPARATIVE STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG NEOPLASMS; LUNG RESECTION; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OPERATIVE BLOOD LOSS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; TIME; TREATMENT OUTCOME;

ADENOCARCINOMA; AGE FACTORS; AGED; BLOOD LOSS, SURGICAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84923104740     PISSN: 13411098     EISSN: 21861005     Source Type: Journal    
DOI: 10.5761/atcs.oa.13-00312     Document Type: Article

References (25)

1. Bongioannini G, Vercellino M, Rugiu MG, et al. Influence of perioperative transfusion therapy on the recurrence potential of locally advanced laryngeal carcinoma. ORL J Otorhinolaryngol Relat Spec 1990; 52: 260-4.
2. Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992; 216: 633-8.
3. Tachibana M, Tabara H, Kotoh T, et al. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. Am J Gastroenterol 1999; 94: 757-65.
4. Chau JK, Harris JR, Seikaly HR. Transfusion as a predictor of recurrence and survival in head and neck cancer surgery patients. J Otolaryngol Head Neck Surg 2010; 39: 516-22.
5. Tartter PI, Burrows L, Kirschner P. Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset N0) non-oat cell lung cancer. J Thorac Cardiovasc Surg 1984; 88: 659-62.
6. Little AG, Wu HS, Ferguson MK, et al. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg 1990; 160: 630-2; discussion 633.
7. Keller SM, Groshen S, Martini N, et al. Blood transfusion and lung cancer recurrence. Cancer 1988; 62: 606-10.
8. Garau I, Benito E, Bosch FX, et al. Blood transfusion has no effect on colorectal cancer survival. A population-based study. Eur J Cancer 1994; 30A: 759-64.
9. Heslin MJ, Gaynor JJ, Newman E, et al. Effect of perioperative blood transfusion on recurrence and survival in 232 primary high-grade extremity sarcoma patients. Ann Surg Oncol 1994; 1: 189-97.
10. Monk BJ, Tewari K, Gamboa-Vujicic G, et al. Does perioperative blood transfusion affect survival in patients with cervical cancer treated with radical hysterectomy? Obstet Gynecol 1995; 85: 343-8.
11. Rzyman W, Dziadziuszko R, Skokowski J, et al. The influence of blood transfusion on survival in operated non-small cell lung cancer patients. J Thorac Cardiovasc Surg 2003; 126: 755-60.
12. Churchhouse AM, Mathews TJ, McBride OM, et al. Does blood transfusion increase the chance of recurrence in patients undergoing surgery for lung cancer? Interact Cardiovasc Thorac Surg 2012; 14: 85-90.
13. Oefelein MG, Colangelo LA, Rademaker AW, et al. Intraoperative blood loss and prognosis in prostate cancer patients undergoing radical retropubic prostatectomy. J Urol 1995; 154: 442-7.
14. Nagai S, Fujii T, Kodera Y, et al. Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas 2011; 40: 3-9.
15. Lehnert T, Methner M, Pollok A, et al. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg 2002; 235: 217-25.
16. Katz SC, Shia J, Liau KH, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 2009; 249: 617-23.
17. Chikamoto A, Beppu T, Masuda T, et al. Amount of operative blood loss affects the long-term outcome after liver resection for hepatocellular carcinoma. Hepatogastroenterology 2012; 59: 1213-6.
18. Goldstraw P. International Association for the Study of Lung Cancer, Staging Manual in Thoracic Oncology. Orange Park: Editorial Rx Press, 2009.
19. Bordin JO, Blajchman MA. Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy. Hematol Oncol Clin North Am 1995; 9: 205-18.
20. Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer. J Thorac Cardiovasc Surg 2012; 143: 815-9.
21. Hoynck van Papendrecht MA, Busch OR, Jeekel J, et al. The influence of blood loss on tumour growth: effect and mechanism in an experimental model. Neth J Surg 1991; 43: 85-8.
22. Yago H, Yoshii H, Naiki M, et al. Stress and murine NK cell function: the role of blood loss. J Clin Lab Immunol 1992; 37: 123-32.
23. Angele MK, Faist E. Clinical review: immunodepression in the surgical patient and increased susceptibility to infection. Crit Care 2002; 6: 298-305.
24. Brahmer JR, Tykodi SS, Chow LQ, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012; 366: 2455-65.
25. Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366: 2443-54.